Observational Study of ALTUS Powered Stapler Used in Bariatric Surgery

September 2, 2024 updated by: Scitech Produtos Medicos Ltda

Post-marketing, Observational Study of ALTUS Powered Stapler Used in Bariatric Surgery

Post-marketing, observational study to evaluate the safety and performance of the ALTUS Powered Stapler in bariatric surgery of "real-world" patients.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Up to 300 patients who underwent sleeve, bypass or revisional bariatric surgery with the use of Altus Powered Stapler will be included in the study. The stapler should be used according to the Instructions for Use and according to the local practice.

The Altus Powered Stapler is used in open or laparoscopic surgeries and simultaneously cuts and staples soft tissues. In order to avoid great physical efforts by the physician and ensure excellent tissue suturing, the cutting and stapling mechanism is driven by the 12-volt battery that comes with the stapler.

Patients will be followed by 7, 30 and 90 days and 12 months after the procedure, as per the research center's standard routine.

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • São Paulo, SP, Brazil, 01331010
        • Hospital IGESP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults (18 years or older), who underwent bariatric surgery with the use of Altus Powered Stapler

Description

Inclusion Criteria:

  • Patients with grade II obesity (BMI ≥ 35 kg/m^2) with one or more associated comorbidities;
  • Patients with grade III obesity (BMI ≥ 40 kg/m^2) regardless of associated diseases;
  • Patients who underwent sleeve, bypass and revisional bariatric surgery procedure with use of the Altus Powered Stapler;
  • The patient must sign and date the informed consent form during a routine follow-up visit, authorizing the use of their surgery data and contact for follow-up.

Exclusion Criteria:

  • Impossibility of collecting data related to the surgical procedure
  • Impossibility of contact with the patient to obtain the informed consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Treated patients
Patients with grade II (with one or more associated comorbidities) and grade III obesity who went through sleeve, bypass and revisional bariatric surgery procedure with the use of Altus Powered Stapler
Stapling performed with ALTUS Powered Stapler

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety - Conversion to open surgery
Time Frame: Intraoperative
Number of conversions to open surgery during the index procedure
Intraoperative
Safety - Number of reinterventions
Time Frame: Up to 1 week
Number of reinterventions within 1 week after the procedure
Up to 1 week
Safety - Postoperative anastomotic leaking and intraluminal/intraperitoneal bleeding
Time Frame: 30 days
Presence of complications of anastomotic leaking and intraluminal/intraperitoneal bleeding within 30 days after procedure
30 days
Safety- Fistula formation
Time Frame: 30 days
Presence of fistula within 30 days after procedure
30 days
Safety - Stenosis
Time Frame: 90 days
Detection of stenosis within 90 days after procedure
90 days
Performance - Procedure Success
Time Frame: Intraoperative
Defined by completion of technique with the device for its intended use
Intraoperative
Performance - Cicatrization of staple line
Time Frame: 90 days
The absence of oozing/bleeding at the staple line
90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative change in weight
Time Frame: 12 months
Defined by preoperative weight (kg) minus postoperative weight (kg) divided by ideal body weight (kg) at the end of 12 months.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2023

Primary Completion (Actual)

July 30, 2024

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

November 18, 2022

First Submitted That Met QC Criteria

November 29, 2022

First Posted (Actual)

December 8, 2022

Study Record Updates

Last Update Posted (Estimated)

September 5, 2024

Last Update Submitted That Met QC Criteria

September 2, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SCI-GE-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Stapler

Subscribe